The timing of an awake assessment is part of the anesthetic strategy.
What the study found
A three-patient adolescent series added remimazolam to dexmedetomidine and remifentanil during selected craniotomy phases. The infusion was stopped in advance of planned awake assessments, and the patients could follow commands during testing.
A deliberately timed awake phase
The authors stopped remimazolam thirty minutes before the planned awake assessments and electrophysiological testing. That interval matters when interpreting the calm emergence and command following. The patients were receiving an actively managed combination, rather than a single isolated injection followed by an immediate test. For an operative reconstruction, the relevant event is therefore the transition between phases, with a separate record of when each infusion changed.
Limits of interpretation
This was a small uncontrolled series using multiple agents. Successful command following does not isolate remimazolam’s contribution, demonstrate complete cognitive recovery or establish suitability for every adolescent.
Implications for case review
Describe the infusion-stop interval and the actual task performed. A drug’s short action does not establish that every patient can immediately complete neurological testing after administration. The report documents one managed sequence, while a forensic assessment needs the operative timeline, co-medications and contemporaneous examination.
Source and related reading
Source: PMC11254310, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: CBT-Assisted Benzodiazepine Discontinuation Evidence Came From Only Three Anxiety Trials.
Leave a Reply